Pharmafile Logo
Pharmafocus logo
Advanced Search
brexit_flag_0

Independent committee report seeks Brexit healthcare clarity

March 21, 2018
Medical Communications, Research and Development ABPI, UK, biotech, brexit, drugs, pharma, pharmaceutical

An independent report, entitled Brexit – Medicines, Medical Devices and Substances of Human Origin and written by the Health and …

News

NICE turns down Dompe’s eye drops for rare eye condition over price concerns

March 21, 2018
Manufacturing and Production, Research and Development, Sales and Marketing Dompe, NICE, cenegermin, neurotrophic keratitis, pharma, rare disease

NICE has announced that it has recommended against the use of Dompe’s recombinant human nerve growth factor eye drop therapy …

News
takeda_global_hq

Takeda completes construction of new global headquarters in Tokyo

March 21, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Japan, Takeda, pharma, tokyo

Japan’s biggest pharmaceutical firm Takeda has announced the completion of construction of its new global headquarters in the country’s capital …

News
dominic_caruso

J&J’s longest-standing CFO finally steps down

March 21, 2018
Medical Communications, Research and Development J&J, JJ, Johnson & Johnson, biotech, cfo, drugs, pharma, pharmaceutical

Johnson & Johnson have revealed that its Chief Financial Officer and Executive Vice President, Dominic J. Caruso, will retire from …

News
celgene_1_02

Celgene bucks trend to strengthen neuroscience pipeline

March 21, 2018
Research and Development, Sales and Marketing Alzheimer's, Celgene, Prothena, biotech, drugs, neuroscience, pharma, pharmaceutical

Celgene has gone against industry movement to back out of the neuroscience area by putting down a potential $2.2 billion …

News
shutterstock_38078521

Heron soars after its painkiller agent reduces pain and opioid use post-surgery at Phase 3

March 20, 2018
Manufacturing and Production, Research and Development heron therapeutics, opioid crisis, opioid epidemic, opioids, painkiller, pharma

Heron Therapeutics has been buoyed by the news that its painkiller agent HTX-011 met all of its primary and secondary …

News
sandoz_3

Novartis steps into the medical marijuana business

March 20, 2018
Manufacturing and Production, Sales and Marketing Medical marijuana, Novartis, Sandoz, biotech, drugs, pharma, pharmaceutical

Canada’s burgeoning medical marijuana industry has finally drawn in a big pharma player. Tilray, a producer of medical cannabis products, …

News
regeneron

Regeneron’s Eylea smashes Phase 3 trial goal in diabetic retinopathy

March 20, 2018
Manufacturing and Production, Research and Development Eylea, Regeneron, diabetes, pharma

Regeneron has confirmed that its vascular endothelial growth factor (VEGF) inhibitor injection Eylea (aflibercept) met its primary endpoint in a …

News
rocheroof

Roche’s immunotherapy improves PFS but unclear long-term benefit in lung cancer

March 20, 2018
Manufacturing and Production, Research and Development Roche, biotech, drugs, pharma, pharmaceutical, tecentriq

Roche’ Tecentriq needs a big result in the immunotherapy space – it initially burst onto the scene as a third-to-market …

News
upper-body-944557_960_720

Vertex “astonished” by NHS England’s response to CF drug

March 20, 2018
Manufacturing and Production, Sales and Marketing Vertex, biotech, cystic fibrosis, drugs, pharma, pharmaceutical

Vertex has been battling to have its treatment, Orkambi, approved in the UK since 2016, when it was first rejected …

News
john_mchutchison

New Chief Science and Medical Officers for Gilead

March 19, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, appointment

Gilead has announced that Dr Norbert Bischofberger, its Chief Scientific Officer (CSO), Executive Vice President of Research and Development and …

Appointment
sperium-2505952_960_720

Male contraceptive pill hits safety goals

March 19, 2018
Research and Development, Sales and Marketing biotech, drugs, male contraceptive, pharma, pharmaceutical

A male contraceptive pill may be edging closer to the market, after a new formulation was shown to be safe …

News

Working Life: Chris Round, Head of EMEA Region, Merck KGaA

March 19, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chris Round, MSD, Merck, Merck KGaA, Working Life, pharma

Merck KGaA’s Chris Round, Head of EMEA Region, spoke with Pharmafile.com to discuss his time at both the US and …

Feature
stem-cell-163711_640

“Game-changer” stem cell transplant shows strength in multiple sclerosis

March 19, 2018
Research and Development, Sales and Marketing Stem cells, multiple sclerosis, pharma

A new stem cell transplant is being hailed as a “game-changer” in the treatment of multiple sclerosis (MS) after an …

News

Lundbeck takes risk on Parkinson’s treatment, €905m on table

March 19, 2018
Sales and Marketing Lundbeck, Parkinson's, biotech, drugs, pharma, pharmaceutical

CNS’ treatments are notoriously risky, especially those that are still at an early stage; however, Lundbeck has decided to take …

News
shutterstock_57369385

India’s Narcotics Control Bureau seizes 55,000 zolpidem tablets in drugs bust

March 19, 2018
Manufacturing and Production, Sales and Marketing India, Narcotics Control Bureau, pharma

India’s drug agency, the Narcotics Control Bureau (NCB), has shut down an illegal trafficking racket in the country in a …

News

Pfizer to hang onto CEO, after 61% pay increase

March 19, 2018
Medical Communications, Sales and Marketing Ian Read, Pfizer, biotech, drugs, pharma, pharmaceutical

Pfizer have given its Chief Executive Officer, Ian Read, a big boost to his pay packet, taking it to $27.9 …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

March 16, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Andrew Witty, AstraZeneca, BMS, Biocon, Martin Shkreli, Novartis, Right to try, US, pharma, top ten

Another week goes by, and we may have finally reached Spring here in the UK. Friday means its time for …

News

Rising levels of opioid prescriptions puts NHS under pressure

March 16, 2018
Medical Communications NHS, biotech, drugs, opioid, pharma, pharmaceutical

It has been found that the number of prescriptions being written for opioid painkillers has risen from 10 million to …

News

NICE recommends Keytruda via CDF as first and only urothelial carcinoma immunotherapy

March 16, 2018
Medical Communications, Sales and Marketing MSD, NICE, immunotherapy, keytruda, pharma

UK drugs watchdog NICE has published its finance guidance recommending the use of MSD’s Keytruda (pembrolizumab) on the NHS through …

News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026